A joint statement from the National Kidney Foundation and the American Society of Nephrology
July 2, 2020
Of the more than 37 million people affected by kidney diseases in the United States, a disproportionate number are of African American, Hispanic, Asian, and Native American descent. African Americans are three times more likely than Non-Hispanic Whites to experience kidney failure. Such disparities go beyond the high...
Investigators present work at the National Kidney Foundation’s virtual Spring Clinicals Meetings
March 25, 2020, New York, NY—Today, the National Kidney Foundation (NKF) showcased a global study designed to understand the experimental immunosuppressant drug Voclosporin as a treatment for patients with lupus kidney disease.
The important study, ...
National Kidney Foundation and CareFirst partnered for the first time on landmark study
New York, NY – November 12, 2019 - A new study conducted by the National Kidney Foundation and CareFirst BlueCross BlueShield (CareFirst) found that detecting chronic kidney disease (CKD) with two...
VICTORIA, British Columbia - (BUSINESS WIRE) - March 14, 2019 - In recognition of World Kidney Day and National Kidney Month, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH/TSX: AUP), a late clinical-stage biopharmaceutical company with research ongoing in two kidney diseases, Lupus Nephritis (LN) and Focal Segmental Glomerulosclerosis (FSGS), today announced a host of activities, including an initiative with the National Kidney...
The National Kidney Foundation Statement about INVOKANA® (Canagliflozin)
New York, NY–Sept. 30, 2019— “The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that their drug INVOKANA® (Canagliflozin) has been approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 diabetes and chronic kidney disease (...
Study was joint effort of the National Kidney Foundation, the U.S. Food and Drug Administration and the European Medicines Agency
New York, NY – August 28, 2019 - The American Journal of Kidney Diseases (AJKD) will publish today an article summarizing the deliberations and recommendations from a Scientific Workshop that was a joint effort of the National Kidney Foundation (NKF), the Food and...
(April 15, 2024, New York, NY) — The National Kidney Foundation (NKF) is delighted to announce that Dr. Suma Nair is the recipient of this year's esteemed Public Service Award. Suma Nair, PhD, MS, RD, is the Associate Administrator for the Health Systems Bureau at the Health Resources and Services Administration (HRSA), U.S....
Update from the Centers for Disease Control and Prevention still shows most with CKD don’t know they have it
New York, NY – July 17, 2019 – The number of American adults who have chronic kidney disease (CKD) is now estimated to be 37 million – that’s one out of every seven or 15 percent of the adult population – according to ...
Dozens of experts, patients and policy makers expected to attend
June 27, 2019, New York, NY – Nearly 80 nephrologists, cardiologists, diabetologists, patients and policy makers will gather in Chicago this week to share information about a human protein called sodium-glucose contransporter-2 (SGLT2), its role in diabetic kidney disease and how a new drug...
